SCHEMBL23601906

SCHEMBL23601906

FCC1(CCc2cc(F)cc(N(CC(F)F)c3nc4nncn4c4ccc(F)cc34)c2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23601511 0.82 CRY1 (0.30)
SCHEMBL23601008 0.80
SCHEMBL23601005 0.80 SMN1; SMN2 (0.33)
SCHEMBL24721230 0.78 PER2 (0.31)
SCHEMBL23601581 0.78
SCHEMBL23601868 0.77
SCHEMBL23601545 0.76
SCHEMBL29909857 0.76
SCHEMBL23576861 0.76
SCHEMBL23601987 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed